Nuo Therapeutics Inc Sustainability Reports
Nuo Therapeutics, Inc. is a commercial-stage biomedical company that develops and commercializes biodynamic wound care therapies. Its flagship product is the Aurix System, an autologous platelet and plasma-derived hematogel designed to stimulate natural healing in chronic wounds.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300H0QI00R4LH8U41
FIGI: BBG00FS7XGZ0
1 reports from 2024 to 2024
